Navigation Links
Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations
Date:9/4/2008

Practice Bulletin for Obstetrician-Gynecologists States UFE Meets Level A Evidence for Clinical Practice Change-Minimally Invasive Interventional Radiology Treatment Is Safe, Effective Option for Women With Uterine Fibroids

FAIRFAX, Va., Sept. 4 /PRNewswire-USNewswire/ -- The Society of Interventional Radiology, a national organization of nearly 4,500 doctors, scientists and allied health professionals dedicated to improving health care through minimally invasive treatment interventions, applauds the recommendations of the American College of Obstetricians and Gynecologists that uterine fibroid embolization "is a safe and effective option" for women. "This finding fully opens the door to women's choice. It will prompt gynecologists to discuss all treatment options for symptomatic uterine fibroids--including UFE--if they are not already doing so," said interventional radiologist John Kaufman, M.D., SIR president.

In its August practice bulletin, "Alternatives to Hysterectomy in the Management of Leiomyomas," ACOG listed UFE among Level A treatment options, meaning that the minimally invasive treatment is considered safe and effective based on long- and short-term outcomes data. Level A evidence is the highest grade possible. The ACOG practice bulletin is used by doctors to aid in making decisions about appropriate patient care. "This is especially significant news for the 200,000 women who have hysterectomies performed annually in the United States to treat symptomatic uterine fibroids. Many of these women can confidently choose UFE," noted Kaufman.

"Women seeking treatment for their fibroids should be aware of all of their treatment options. UFE may be one of those options, and the best way to determine this is to for the woman and her gynecologist to consult with an interventional radiologist," said Kaufman. "The procedure is widely available, and finding an interventional radiologist who performs UFE is easy. The online SIR physician directory specifically identifies interventional radiologists with expertise in this area," he added. Interventional radiologists often use imaging tests such as MRI to help determine whether a woman is a candidate for UFE. Sometimes additional important information about the pelvic organs is found that helps the woman choose her best treatment option.

Uterine fibroids are benign tumors that can cause prolonged, heavy menstrual bleeding that can be severe enough to cause anemia or require transfusion; disabling pelvic pain and pressure; urinary frequency; pain during intercourse; and miscarriage. Twenty to 40 percent of women age 35 and older have uterine fibroids of a significant size; African-American women are at a higher risk for fibroids (as many as 50 percent have fibroids of a significant size).

Pioneered and performed by interventional radiologists, UFE blocks tiny blood vessels that feed fibroids, causing the tumor to die and symptoms to subside. An interventional radiologist uses imaging to guide a thin catheter to the uterine artery to treat the source of the disease internally, avoiding open surgery. The procedure offers less risk, less pain and a shorter recovery time compared to open surgery.

The ACOG practice bulletin notes, "Based on long- and short-term outcomes, uterine artery embolization (UAE) is a safe and effective option for appropriately selected women who wish to retain their uteri." It compares UAE, also referred to as UFE, to other treatment methods and favorably points out the large amount of peer-reviewed literature illustrating its effectiveness. It indicates that women who want to choose UFE "should have a thorough evaluation with an obstetrician-gynecologist to help facilitate optimal collaboration with the interventional radiologist and to ensure the appropriateness of therapy, taking into account the reproductive wishes of the patient."

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, usually in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine.

Today, interventional radiology treatments are first-line care for many conditions that once required surgery. Interventional radiology treatments generally offer less risk, less pain and less recovery time compared to open surgery. In 2008, the Society of Interventional Radiology (SIR) celebrates 35 years of quality patient care innovation. Visit http://www.SIRweb.org.


'/>"/>
SOURCE Society of Interventional Radiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology
2. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
3. TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
5. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
6. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
7. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
8. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
9. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
10. Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
11. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Dickinson Insurance and Financial Services, a ... services, is providing an update on a charitable event that began earlier this ... a locally recognized nonprofit that provides shelter and care for animals seeking new ...
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... Pekin, IL (PRWEB) , ... October 13, 2017 ... ... Foundation, which established the certification process to promote standards of excellence for the ... iaedp™ Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton ... staged a mock evacuation of the facility as part of a disaster drill on ... Echo Hose EMS and Shelton City Emergency Manager, as well as the Connecticut ...
Breaking Medicine News(10 mins):